Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Metabolic Syndrome × Pyruvic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Warts 1 Metabolic Syndrome 1 Heart Failure 1 Cardiovascular Diseases 1

Interventions

Metformin 7 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Pioglitazone 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Naltrexone 1 Medical History Taking 1 Liraglutide 1 Leuprolide 1 Human Growth Hormone 1 Hepatectomy 1 Hematologic Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06645691 2024-12-06

POLARIC-13

National Heart Centre Singapore

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡